tradingkey.logo

Alphatec Holdings Inc

ATEC
20.835USD
+0.595+2.94%
Market hours ETQuotes delayed by 15 min
3.11BMarket Cap
LossP/E TTM

Alphatec Holdings Inc

20.835
+0.595+2.94%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Alphatec Holdings Inc

Currency: USD Updated: 2025-11-10

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Alphatec Holdings Inc's Score

Industry at a Glance

Industry Ranking
40 / 209
Overall Ranking
117 / 4611
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 12 analysts
Buy
Current Rating
23.750
Target Price
+19.95%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Alphatec Holdings Inc Highlights

StrengthsRisks
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patients’ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 74.30% year-on-year.
Undervalued
The company’s latest PE is -19.39, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 102.46M shares, decreasing 7.72% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 640.17K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.28.

Financial Health

Currency: USD Updated: 2025-11-10

The company's current financial score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 196.50M, representing a year-over-year increase of 30.38%, while its net profit experienced a year-over-year increase of 27.86%.

Score

Industry at a Glance

Previous score
8.00
Change
0

Financials

5.93

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

6.47

Operational Efficiency

10.00

Growth Potential

10.00

Shareholder Returns

7.62

Alphatec Holdings Inc's Company Valuation

Currency: USD Updated: 2025-11-10

The company’s current valuation score is 6.76, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -19.39, which is -79.75% below the recent high of -3.93 and 0.00% above the recent low of -19.39.

Score

Industry at a Glance

Previous score
6.76
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 40/209
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-10

The company’s current earnings forecast score is 8.17, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Alphatec Holdings Inc is 24.00, with a high of 27.00 and a low of 20.00.

Score

Industry at a Glance

Previous score
8.17
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 12 analysts
Buy
Current Rating
23.750
Target Price
+19.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

110
Total
7
Median
9
Average
Company name
Ratings
Analysts
Alphatec Holdings Inc
ATEC
12
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
32
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
30
1
2
3
...
22

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-10

The company’s current price momentum score is 9.58, which is higher than the Healthcare Equipment & Supplies industry's average of 7.00. Sideways: Currently, the stock price is trading between the resistance level at 22.86 and the support level at 15.40, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.57
Change
0.01

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(1)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.761
Buy
RSI(14)
81.963
Overbought
STOCH(KDJ)(9,3,3)
89.342
Overbought
ATR(14)
0.929
High Vlolatility
CCI(14)
92.922
Neutral
Williams %R
7.780
Overbought
TRIX(12,20)
1.323
Sell
StochRSI(14)
85.730
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
19.738
Buy
MA10
18.644
Buy
MA20
16.932
Buy
MA50
15.720
Buy
MA100
14.299
Buy
MA200
12.749
Buy

Institutional Confidence

Currency: USD Updated: 2025-11-10

The company’s current institutional recognition score is 5.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 68.97%, representing a quarter-over-quarter decrease of 18.52%. The largest institutional shareholder is The Vanguard, holding a total of 6.79M shares, representing 4.57% of shares outstanding, with 8.93% increase in holdings.

Score

Industry at a Glance

Previous score
5.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Squadron Capital LLC
11.40M
--
BlackRock Institutional Trust Company, N.A.
8.16M
+10.17%
The Vanguard Group, Inc.
Star Investors
6.63M
+10.63%
American Century Investment Management, Inc.
6.18M
+5.95%
L-5 Healthcare Partners LLC
6.07M
-24.92%
Miles (Patrick S)
4.85M
-5.83%
Braidwell LP
3.64M
-14.66%
BNP Paribas Asset Management USA, Inc.
4.01M
-5.26%
State Street Investment Management (US)
2.76M
-2.28%
Geode Capital Management, L.L.C.
2.70M
+7.38%
1
2

Risk Assessment

Currency: USD Updated: 2025-11-10

The company’s current risk assessment score is 6.05, which is higher than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 1.09. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.

Score

Industry at a Glance

Previous score
6.05
Change
0
Beta vs S&P 500 index
1.09
VaR
+5.17%
240-Day Maximum Drawdown
+26.02%
240-Day Volatility
+61.39%

Return

Best Daily Return
60 days
+16.29%
120 days
+30.15%
5 years
+39.68%
Worst Daily Return
60 days
-4.51%
120 days
-6.36%
5 years
-34.26%
Sharpe Ratio
60 days
+2.56
120 days
+1.78
5 years
+0.41

Risk Assessment

Maximum Drawdown
240 days
+26.02%
3 years
+73.51%
5 years
+73.51%
Return-to-Drawdown Ratio
240 days
+3.89
3 years
+0.36
5 years
+0.09
Skewness
240 days
+2.88
3 years
+0.78
5 years
+0.56

Volatility

Realised Volatility
240 days
+61.39%
5 years
+63.69%
Standardised True Range
240 days
+2.84%
5 years
+3.04%
Downside Risk-Adjusted Return
120 days
+549.86%
240 days
+549.86%
Maximum Daily Upside Volatility
60 days
+50.27%
Maximum Daily Downside Volatility
60 days
+40.78%

Liquidity

Average Turnover Rate
60 days
+1.48%
120 days
+1.40%
5 years
--
Turnover Deviation
20 days
+28.01%
60 days
+3.06%
120 days
-2.45%

Peer Comparison

Healthcare Equipment & Supplies
Alphatec Holdings Inc
Alphatec Holdings Inc
ATEC
7.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.55 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.53 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI